4.6 Review

The Interplay of the Unfolded Protein Response in Neurodegenerative Diseases: A Therapeutic Role of Curcumin

期刊

FRONTIERS IN AGING NEUROSCIENCE
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2021.767493

关键词

Alzheimer's disease; Parkinson's disease; neurodegenaration; unfolded protein response; ER stress; curcumin; ROS-reactive oxygen species; cell death

资金

  1. Ramalingaswami grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/RLF/Re-entry/18/2017]
  2. Planning and Budgeting Committee (PBC) outstanding postdoctoral fellowship, Israel

向作者/读者索取更多资源

The abnormal accumulation of misfolded proteins in the endoplasmic reticulum and their aggregation lead to inflammation, endoplasmic reticulum stress, and the development of neurodegenerative diseases. Curcumin, a mixture of low molecular weight polyphenolic compounds from turmeric, has shown promising effects in preventing various diseases, including SARS-CoV-2 infection and neurodegenerative disorders by regulating the unfolded protein response.
Abnormal accumulation of misfolded proteins in the endoplasmic reticulum and their aggregation causes inflammation and endoplasmic reticulum stress. This promotes accumulation of toxic proteins in the body tissues especially brain leading to manifestation of neurodegenerative diseases. The studies suggest that deregulation of proteostasis, particularly aberrant unfolded protein response (UPR) signaling, may be a common morbific process in the development of neurodegeneration. Curcumin, the mixture of low molecular weight polyphenolic compounds from turmeric, Curcuma longa has shown promising response to prevents many diseases including current global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and neurodegenerative disorders. The UPR which correlates positively with neurodegenerative disorders were found affected by curcumin. In this review, we examine the evidence from many model systems illustrating how curcumin interacts with UPR and slows down the development of various neurodegenerative disorders (ND), e.g., Alzheimer's and Parkinson's diseases. The recent global increase in ND patients indicates that researchers and practitioners will need to develop a new pharmacological drug or treatment to manage and cure these neurodegenerative diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据